Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97


Differential proteomic analysis of cancer stem cell properties in hepatocellular carcinomas by isobaric tag labeling and mass spectrometry.

Ko CH, Cheng CF, Lai CP, Tzu TH, Chiu CW, Lin MW, Wu SY, Sun CY, Tseng HW, Wang CC, Kuo ZK, Wang LM, Chen SF.

J Proteome Res. 2013 Aug 2;12(8):3573-85. doi: 10.1021/pr4004294. Epub 2013 Jul 17.


Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells.

Cheung PF, Cheng CK, Wong NC, Ho JC, Yip CW, Lui VC, Cheung AN, Fan ST, Cheung ST.

PLoS One. 2011;6(12):e28246. doi: 10.1371/journal.pone.0028246. Epub 2011 Dec 16.


DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma.

Xu X, Liu RF, Zhang X, Huang LY, Chen F, Fei QL, Han ZG.

Mol Cancer Ther. 2012 Mar;11(3):629-38. doi: 10.1158/1535-7163.MCT-11-0531. Epub 2012 Jan 11.


Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.

Park JR, Kim RJ, Lee YK, Kim SR, Roh KJ, Oh SH, Kong G, Kang KS, Nam JS.

J Hepatol. 2011 Jan;54(1):122-31. doi: 10.1016/j.jhep.2010.06.026. Epub 2010 Aug 26.


Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.

Liu WT, Jing YY, Yu GF, Han ZP, Yu DD, Fan QM, Ye F, Li R, Gao L, Zhao QD, Wu MC, Wei LX.

Cancer Lett. 2015 Mar 28;358(2):136-43. doi: 10.1016/j.canlet.2014.12.019. Epub 2014 Dec 12.


Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells in vitro and in vivo.

Jabari S, Meissnitzer M, Quint K, Gahr S, Wissniowski T, Hahn EG, Neureiter D, Ocker M.

Int J Oncol. 2009 Jul;35(1):69-80.


Gene expression profiling of liver cancer stem cells by RNA-sequencing.

Ho DW, Yang ZF, Yi K, Lam CT, Ng MN, Yu WC, Lau J, Wan T, Wang X, Yan Z, Liu H, Zhang Y, Fan ST.

PLoS One. 2012;7(5):e37159. doi: 10.1371/journal.pone.0037159. Epub 2012 May 14.


Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.

Ali N, Allam H, May R, Sureban SM, Bronze MS, Bader T, Umar S, Anant S, Houchen CW.

J Virol. 2011 Dec;85(23):12292-303. doi: 10.1128/JVI.05920-11. Epub 2011 Sep 21.


Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.

Liu S, Li N, Yu X, Xiao X, Cheng K, Hu J, Wang J, Zhang D, Cheng S, Liu S.

Gastroenterology. 2013 May;144(5):1031-1041.e10. doi: 10.1053/j.gastro.2013.01.046. Epub 2013 Jan 31.


Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.

Leth-Larsen R, Terp MG, Christensen AG, Elias D, Kühlwein T, Jensen ON, Petersen OW, Ditzel HJ.

Mol Med. 2012 Sep 25;18:1109-21. doi: 10.2119/molmed.2012.00091.


Role of stem cells in normal liver and cancer.

Lau CK, Yang ZF, Fan ST.

Anticancer Agents Med Chem. 2011 Jul;11(6):522-8. Review.


Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.

Muramatsu S, Tanaka S, Mogushi K, Adikrisna R, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Nakayama K, Tanaka H, Yamaoka S, Arii S.

Hepatology. 2013 Jul;58(1):218-28. doi: 10.1002/hep.26345. Epub 2013 May 27.


Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.

Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H.

Hepatology. 2006 Jul;44(1):240-51.


Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.

Yi X, Luk JM, Lee NP, Peng J, Leng X, Guan XY, Lau GK, Beretta L, Fan ST.

Mol Cell Proteomics. 2008 Feb;7(2):315-25. Epub 2007 Oct 14.


Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion.

Cokakli M, Erdal E, Nart D, Yilmaz F, Sagol O, Kilic M, Karademir S, Atabey N.

BMC Cancer. 2009 Feb 24;9:65. doi: 10.1186/1471-2407-9-65.


Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.

Mosca E, Cocola C, Sabour D, Pelucchi P, Bertalot G, Palumbo O, Carella M, Götte M, Schöler HR, Reinbold R, Zucchi I, Milanesi L.

In Silico Biol. 2010;10(5-6):207-21. doi: 10.3233/ISB-2010-0437.


Stem-like cells in hepatitis B virus-associated cirrhotic livers and adjacent tissue to hepatocellular carcinomas possess the capacity of tumorigenicity.

Sun YL, Yin SY, Xie HY, Zhou L, Xue F, Wu LM, Gao F, Zheng SS.

J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1280-6. doi: 10.1111/j.1440-1746.2008.05342.x. Epub 2008 May 7.


Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.

Chiba T, Kamiya A, Yokosuka O, Iwama A.

Cancer Lett. 2009 Dec 28;286(2):145-53. doi: 10.1016/j.canlet.2009.04.027. Epub 2009 May 22. Review.


Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.

Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z.

BMC Gastroenterol. 2011 Jun 14;11:71. doi: 10.1186/1471-230X-11-71.


Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.

Yu Y, Shen H, Yu H, Zhong F, Zhang Y, Zhang C, Zhao J, Li H, Chen J, Liu Y, Yang P.

Mol Biosyst. 2011 Jun;7(6):1908-16. doi: 10.1039/c0mb00265h. Epub 2011 Apr 6.


Supplemental Content

Support Center